This study investigates pancreatic ductal cancer. It looks at how an investigational medication might work when given before surgery and followed by chemotherapy.
The study evaluates the safety and effectiveness of the investigational medication. It focuses on how well the treatment works and its potential side effects.
- Who can participate: Adults with localized pancreatic cancer that can be removed by surgery may join. Participants must not have had prior therapy and must test positive for a specific protein in their tumor.
- Study details: Participants will receive an investigational medication before surgery and then standard chemotherapy after surgery. A placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine, is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand